The transfer of Flexor Hallucis Longus (FHL) in the management of chronic Achilles tendon ruptures has demonstrated good functional outcome, but an extensive surgical field at a vulnerable location may lead to increased risk for soft tissue problems. The arthroscopic FHL transfer may reduce the risk for soft tissue problems. Functional outcome parameters are investigated, wound/soft tissue complications registered.
The transfer of FHL in the management of chronic Achilles tendon ruptures has demonstrated good functional outcome with American Orthopaedic Foot ane Ankle Society (AOFAS) hindfoot scores at 80-89. The extensive surgical field by either a two-incision approach or a single longitudinal posterior approach to the Achilles tendon may lead to an increased risk for soft tissue problems, both infections and wound healing problems. The endoscopic FHL transfer may reduce the risk for soft tissue problems while retaining a good functional outcome. Several functional outcome measures and scores are evaluated a year after surgery. Prospective study for evaluation of the surgical procedure.
Study Type
OBSERVATIONAL
Enrollment
38
endoscopic transfer og flexor hallucis longus
Oslo University Hospital
Oslo, Norway
The Victorian Institute of Sports Assessment- Achilles Questionnaire (VISA-A) outcome score
Time frame: one year after FHL transfer
Visual Analogue Scale for Pain (VAS pain) score
patient reported outcome
Time frame: 3, 6 and 12 months after FHL transfer
patient reported function score (PRFS)
patient reported Activity related disability
Time frame: 6, 12 months
Magnetic resonance imagine (MRI)
FHL hypertrophy
Time frame: one year post surgery
functional test battery
jump- and strength tests
Time frame: 12 months
local wound conditions
wound infection
Time frame: within 12 weeks
AOFAS hindfoot
Time frame: 3,6,12 months
VISA-A
Time frame: 6 months after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.